scholarly journals Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity

2012 ◽  
Vol 21 (16) ◽  
pp. 3558-3567 ◽  
Author(s):  
Fernando Morales ◽  
Jillian M. Couto ◽  
Catherine F. Higham ◽  
Grant Hogg ◽  
Patricia Cuenca ◽  
...  
Gene ◽  
2013 ◽  
Vol 522 (2) ◽  
pp. 226-230 ◽  
Author(s):  
Ashok Kumar ◽  
Sarita Agarwal ◽  
Divya Agarwal ◽  
Shubha R. Phadke

2013 ◽  
Vol 48 (1) ◽  
pp. 105-108 ◽  
Author(s):  
Kenji Jinnai ◽  
Maki Mitani ◽  
Naonobu Futamura ◽  
Kunihiko Kawamoto ◽  
Itaru Funakawa ◽  
...  

2004 ◽  
Vol 280 (2) ◽  
pp. 941-952 ◽  
Author(s):  
Marzena Wojciechowska ◽  
Albino Bacolla ◽  
Jacquelynn E. Larson ◽  
Robert D. Wells

Author(s):  
Eric J. Montemayor ◽  
Johanna M. Virta ◽  
Lauren D. Hagler ◽  
Steven C. Zimmerman ◽  
Samuel E. Butcher

The structure of a 22-base-pair RNA helix with mismatched pyrimidine base pairs is reported. The helix contains two symmetry-related CUG sequences: a triplet-repeat motif implicated in myotonic dystrophy type 1. The CUG repeat contains a U–U mismatch sandwiched between Watson–Crick pairs. Additionally, the center of the helix contains a dimerized UUCG motif with tandem pyrimidine (U–C/C–U) mismatches flanked by U–G wobble pairs. This region of the structure is significantly different from previously observed structures that share the same sequence and neighboring base pairs. The tandem pyrimidine mismatches are unusual and display sheared, cross-strand stacking geometries that locally constrict the helical width, a type of stacking previously associated with purines in internal loops. Thus, pyrimidine-rich regions of RNA have a high degree of structural diversity.


Neurology ◽  
2019 ◽  
Vol 93 (10) ◽  
pp. e995-e1009 ◽  
Author(s):  
Sarah A. Cumming ◽  
Cecilia Jimenez-Moreno ◽  
Kees Okkersen ◽  
Stephan Wenninger ◽  
Ferroudja Daidj ◽  
...  

ObjectiveTo evaluate the role of genetic variation at the DMPK locus on symptomatic diversity in 250 adult, ambulant patients with myotonic dystrophy type 1 (DM1) recruited to the Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve Quality of Life—Standards, a Target Identification Collaboration (OPTIMISTIC) clinical trial.MethodsWe used small pool PCR to correct age at sampling biases and estimate the progenitor allele CTG repeat length and somatic mutational dynamics, and AciI digests and repeat primed PCR to test for the presence of variant repeats.ResultsWe confirmed disease severity is driven by progenitor allele length, is further modified by age, and, in some cases, sex, and that patients in whom the CTG repeat expands more rapidly in the soma develop symptoms earlier than predicted. We revealed a key role for variant repeats in reducing disease severity and quantified their role in delaying age at onset by approximately 13.2 years (95% confidence interval 5.7–20.7, 2-tailed t test t = −3.7, p = 0.0019).ConclusionsCareful characterization of the DMPK CTG repeat to define progenitor allele length and presence of variant repeats has increased utility in understanding clinical variability in a trial cohort and provides a genetic route for defining disease-specific outcome measures, and the basis of treatment response and stratification in DM1 trials.


2012 ◽  
Vol 260 (4) ◽  
pp. 998-1003 ◽  
Author(s):  
Vincent Huin ◽  
Francis Vasseur ◽  
Susanna Schraen-Maschke ◽  
Claire-Marie Dhaenens ◽  
Patrick Devos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document